257 OPERATIONAL CHALLENGES FOR IMPLEMENTING THE “TORONTO PROTOCOL“, GLECAPREVIR/PIBRENTASVIR+EZETIMIBE, FOR SOLID ORGAN TRANSPLANTATION FROM HCV NAT+ DONORS TO HCV-UNINFECTED RECIPIENTS

Gastroenterology(2023)

引用 0|浏览1
暂无评分
关键词
organ transplantation,solid organ transplantation,glecaprevir/pibrentasvir+ezetimibe,hcv-uninfected
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要